MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
COMPLETEDNCT00006251·PHASE1 / PHASE2·Fred Hutchinson Cancer Center·21 enrolled
total-body irradiationfludarabine phosphatecyclosporinemycophenolate mofetilnonmyeloablative allogeneic hematopoietic stem cell transplantation+3 more
Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00058292·PHASE1·Northwestern University·44 enrolled
filgrastimrituximabCarmustinecytarabineetoposide+3 more
S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
COMPLETEDNCT00005089·PHASE2·SWOG Cancer Research Network·71 enrolled
rituximabcyclophosphamidedoxorubicin hydrochlorideprednisonevincristine sulfate+1 more
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
COMPLETEDNCT00006083·PHASE3·Jonsson Comprehensive Cancer Center
Fragminplacebo
PS-341 in Treating Patients With Hematologic Cancer
COMPLETEDNCT00006098·PHASE1·Memorial Sloan Kettering Cancer Center
bortezomib
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
COMPLETEDNCT00005639·PHASE1·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·34 enrolled
Azacitidine Injectionsodium phenylbutyrate
Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma
COMPLETEDNCT00006241·PHASE2·Fred Hutchinson Cancer Center
filgrastimchemotherapyin vitro-treated peripheral blood stem cell transplantationperipheral blood stem cell transplantationradiation therapy
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
COMPLETEDNCT00006373·PHASE2·H. Lee Moffitt Cancer Center and Research Institute·27 enrolled
etoposideifosfamidetopotecan hydrochlorideautologous bone marrow transplantationMesna
VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL
COMPLETEDNCT00274794·NA·The Cleveland Clinic·55 enrolled
filgrastimrituximab
Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
COMPLETEDNCT00005074·PHASE2·NCIC Clinical Trials Group·33 enrolled
alvocidib
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
COMPLETEDNCT00004132·PHASE2·Jonsson Comprehensive Cancer Center
filgrastimpalifermincyclophosphamideetoposideifosfamide+2 more
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00006350·PHASE2·University of Maryland, Baltimore
daclizumabtherapeutic allogeneic lymphocytesmycophenolate mofetiltacrolimusperipheral blood stem cell transplantation
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
COMPLETEDNCT00005634·PHASE1·Memorial Sloan Kettering Cancer Center
vorinostat
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
COMPLETEDNCT00716911·NA·City of Hope Medical Center·100 enrolled
ganciclovirpolymerase chain reactionflow cytometryimmunologic techniqueallogeneic bone marrow transplantation+3 more
Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
WITHDRAWNNCT00005998·PHASE2·Masonic Cancer Center, University of Minnesota
carmustinecyclophosphamidecytarabinedexamethasoneetoposide+6 more
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma
COMPLETEDNCT00005040·PHASE2·Memorial Sloan Kettering Cancer Center
arsenic trioxide
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00005854·PHASE2·Fred Hutchinson Cancer Center
cyclophosphamidecyclosporinemethotrexateallogeneic bone marrow transplantationin vitro-treated bone marrow transplantation+1 more
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
TERMINATEDNCT00004239·PHASE1·Alliance for Clinical Trials in Oncology·10 enrolled
Compound 506U78
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
COMPLETEDNCT00004258·PHASE1·Indiana University School of Medicine·40 enrolled
cilengitide
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00006042·PHASE1·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
filgrastimcyclophosphamidefludarabine phosphatemycophenolate mofetiltacrolimus+2 more
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
COMPLETEDNCT00005805·PHASE3·Memorial Sloan Kettering Cancer Center
St. John's wort
Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
COMPLETEDNCT00004101·PHASE1·National Cancer Institute (NCI)·35 enrolled
apolizumab
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
COMPLETEDNCT00112593·NA·Fred Hutchinson Cancer Center·5 enrolled
fludarabine phosphatetotal-body irradiationperipheral blood stem cell transplantationcyclosporinemycophenolate mofetil+1 more
PS-341 in Treating Patients With Advanced Cancer
COMPLETEDNCT00006362·PHASE1·Mayo Clinic
bortezomib
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00044954·PHASE2·University of Texas Southwestern Medical Center
therapeutic allogeneic lymphocytescyclosporinefludarabine phosphatemycophenolate mofetilallogeneic bone marrow transplantation+2 more
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer
COMPLETEDNCT00006225·PHASE1 / PHASE2·Northwestern University
filgrastimrecombinant flt3 ligandrecombinant human thrombopoietinrecombinant interleukin-3in vitro-treated peripheral blood stem cell transplantation
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
COMPLETEDNCT00612716·PHASE2·Masonic Cancer Center, University of Minnesota·6 enrolled
busulfancyclophosphamideStem cell infusionTotal body irradiation
Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
COMPLETEDNCT00004231·PHASE2·Northwestern University
aldesleukinfilgrastimrecombinant interferon alfabusulfancyclophosphamide+10 more
Stem Cell Transplantation in Treating Patients With Hematologic Cancer
COMPLETEDNCT00004904·PHASE1·Northwestern University
anti-thymocyte globulinfilgrastimcladribinecyclophosphamideetoposide+4 more
Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer
COMPLETEDNCT00004189·PHASE1·National Cancer Institute (NCI)·40 enrolled
filgrastimbecatecarincisplatin